Mirae Asset Global Investments’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-270,396
Closed -$1.12M 2616
2023
Q4
$1.12M Buy
270,396
+11,387
+4% +$47.1K ﹤0.01% 1559
2023
Q3
$777K Sell
259,009
-79,936
-24% -$240K ﹤0.01% 1666
2023
Q2
$834K Buy
338,945
+49,999
+17% +$123K ﹤0.01% 1676
2023
Q1
$653K Buy
288,946
+9,531
+3% +$21.5K ﹤0.01% 1798
2022
Q4
$975K Buy
279,415
+207,382
+288% +$724K ﹤0.01% 1510
2022
Q3
$2.67M Buy
72,033
+28,589
+66% +$1.06M 0.01% 1025
2022
Q2
$519K Buy
+43,444
New +$519K ﹤0.01% 1732